🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Prelude Therapeutics Incorporated
Market Cap: Low
Employees: Low
PRT543
Prelude Therapeutics Incorporated is a clinical-stage precision oncology company focusing on novel precision cancer medicines, including products like PRT543, PRT811, PRT1419, PRT2527, and others at various stages of development or trials.
Website
About | Leadership | Directors | About | Contact | Contact | Careers | Careers | Jobs | About | About
Symbol: PRLD
Recent Price: $1.21
Industry: Biotechnology
CEO: Dr. Krishna Vaddi D.V.M., Ph.D.
Sector: Healthcare
Employees: 128
Address: 200 Powder Mill Road, Wilmington, DE 19803
Phone: 302 467 1280
Leadership
- Kris Vaddi, Ph.D., Chief Executive Officer
- Jane Huang, M.D., President and Chief Medical Officer
- Bryant Lim, Chief Legal Officer, Corporate Secretary & Interim Chief Financial Officer
- Andrew Combs, Ph.D., Chief Chemistry Officer
- Peggy Scherle, Ph.D., Chief Scientific Officer
- Michele Porreca, M.B.A., Chief People Officer
- Sean Brusky, M.B.A., Chief Business Officer
- Naveen Babbar, Ph.D., Senior Vice President, Translation Medicine
- Aimee Crombie, Ph.D., SVP & Head of Strategic Planning & Operations
- Robert Doody, Senior Vice President, Investor Relations
- Wan-Jen Hong, M.D., Senior Vice President, Clinical Development
- Bill Novotny, M.D., Senior Vice President, Clinical Development
- Madhu Pudipeddi, Ph.D., Senior Vice President, Technical Operations
- Paul A. Friedman, M.D., Chair
- David Bonita, M.D., Director
- Julian C. Baker, Director
- Mardi C. Dier, Director
- Victor Sandor, M.D., Director
- Martin Babler, Director
Last updated: 2024-12-31